Patents Assigned to I-Property Holding Corp.
-
Patent number: 11042738Abstract: A simple and quick verification of the authenticity of a blister of elements, such as pills in the pharmaceutical industry, is provided. The pills packaged in a blister can be authenticated using mobile imaging devices such as a mobile smartphone. Generally speaking, an image of the pills and their differentiating physical characteristics in the blister is acquired and compared to at least one code which is marked on the blister itself. This code may also be encrypted. A dedicated software application on the mobile smartphone can be used to decrypt the code and compare the code to the image of the pills in the blister, to thereby evaluate authenticity of the blister and its contents.Type: GrantFiled: April 22, 2016Date of Patent: June 22, 2021Assignee: I-Property Holding Corp.Inventor: Alexander Stuck
-
Patent number: 10363221Abstract: A solid pharmaceutical dosage form has micro- or nanostructures impressed on the surface thereof or an interface thereof. The dosage form includes a suitable quantity and distribution of ingredients, such as one or more dyes, so as to enhance the optical contrast effect caused by the micro- or nanostructures so that the micro- or nanostructures are observable by the human eye and thereby able to provide anti-counterfeiting characteristics to the dosage form.Type: GrantFiled: April 16, 2010Date of Patent: July 30, 2019Assignee: I-Property Holding Corp.Inventors: Stefan Klocke, Harald Walter, Alexander Stuck
-
Patent number: 9378445Abstract: This inventive method assures the authenticity of drugs or other valuable substances that reside within product containers, such as syringes. The method includes initially measuring the 3D topology of the glass surface while determining the distance to the glass surface. Thereafter, a desired 3D code is written below the glass surface with a pulsed laser system. The written 3D code is readable using optical coherence topography (OCT) or parallel optical coherence tomography (pOCT) to verify the authenticity of the product container. A system uses this method with a plurality of syringes held within a tray, and a writing apparatus that moves relative to the tray to write a predetermined 3D code on each of the syringes held in the tray, during processing of the syringes along a process line while in the tray.Type: GrantFiled: June 18, 2012Date of Patent: June 28, 2016Assignee: I-Property Holding Corp.Inventors: Alexander Stuck, Stefan Klocke, Paul Glendenning
-
Patent number: 9189728Abstract: The present invention relates to a method for the authentication of dosage forms such as tablets, in particular pharmaceutical tablets, by reading, i.e. detecting, code structure from the tablet, reading additional information from the package or on an information sheet, and then comparing the readings to verify authenticity. The code structure may be randomized on a plurality of tablets disposed in identifiable locations in a shared package such that the detected code structures define a unique digital signature for the package of tablets.Type: GrantFiled: January 20, 2011Date of Patent: November 17, 2015Assignee: I-Property Holding Corp.Inventors: Alexander Stuck, Stefan Klocke, Thomas Gering, Harald Walter
-
Publication number: 20140353381Abstract: This inventive method assures the authenticity of drugs or other valuable substances that reside within product containers, such as syringes. The method includes initially measuring the 3D topology of the glass surface while determining the distance to the glass surface. Thereafter, a desired 3D code is written below the glass surface with a pulsed laser system. The written 3D code is readable using optical coherence topography (OCT) or parallel optical coherence tomography (pOCT) to verify the authenticity of the product container. A system uses this method with a plurality of syringes held within a tray, and a writing apparatus that moves relative to the tray to write a predetermined 3D code on each of the syringes held in the tray, during processing of the syringes along a process line while in the tray.Type: ApplicationFiled: June 18, 2012Publication date: December 4, 2014Applicant: I-PROPERTY HOLDING CORP.Inventors: Alexander Stuck, Stefan Klocke, Paul Glendenning
-
Publication number: 20140255482Abstract: A solid pharmaceutical dosage form [19] has micro- or nanostructures [10a, 10b, 10c, 10d] impressed on the surface thereof or an interface thereof. The dosage form [19] includes a suitable quantity and distribution of ingredients, such as one or more dyes, so as to enhance the optical contrast effect, C, caused by the micro- or nanostructures so that the micro- or nanostructures are observable by the human eye and thereby able to provide anti-counterfeiting characteristics to the dosage form.Type: ApplicationFiled: April 16, 2010Publication date: September 11, 2014Applicant: I-Property Holding Corp.Inventors: Stefan Klocke, Harald Walter, Alexander Stuck
-
Patent number: 8715725Abstract: The present invention relates to a verification method for tracking and tracing tablets, particularly pharmaceutical tablets. It further relates to a visible secure marking or information that is a part of such tablet (10). The invention further relates to tablets suitable for such verification method, processes for manufacturing such tablets, and methods for reading the information.Type: GrantFiled: January 20, 2011Date of Patent: May 6, 2014Assignee: I-Property Holding Corp.Inventors: Alexander Stuck, Stefan Klocke, Harald Walter
-
Patent number: 8626672Abstract: A method of tracking and tracing tablets, in particular pharmaceutical tablets, includes reading, i.e. detecting, code structure from the tablet, reading additional information from the package on an information sheet, and then comparing the readings to verify authenticity. The code structure may be two-dimensional or three-dimensional. The detected code may further be compared with information stored in a database.Type: GrantFiled: July 22, 2010Date of Patent: January 7, 2014Assignee: I-Property Holding Corp.Inventors: Alexander Stuck, Stefan Klocke, Harald Walter
-
Patent number: 8323623Abstract: A pharmaceutical dosage form [11, 11g] has reduced susceptibility to counterfeiting, due to the forming directly thereon of a pattern or base layer [10, 10g] of a Moiré pair, wherein a Moiré effect is visually observable by looking through a revealing layer [12, 12g] positioned closely to and superimposed on the base layer [10, 10g]. The pattern fanned on the pharmaceutical dosage form [11, 11g] may be formed by embossing, oblation, inkjet printing, or tampon printing. The revealing layer [12, 12g] of the Moiré pair can be part of a blister package containing the pharmaceutical dosage form [11, 11g], so that the Moiré effect is observable while looking at the pharmaceutical dosage form [11, 11g] as it remains within the package.Type: GrantFiled: April 16, 2010Date of Patent: December 4, 2012Assignee: I-Property Holding Corp.Inventors: Stefan Klocke, Harald Walter, Alexander Stuck
-
Publication number: 20110256069Abstract: A pharmaceutical dosage form [11, 11g] has reduced susceptibility to counterfeiting, due to the forming directly thereon of a pattern or base layer [10, 10g] of a Moiré pair, wherein a Moiré effect is visually observable by looking through a revealing layer [12, 12g] positioned closely to and superimposed on the base layer [10, 10g]. The pattern fanned on the pharmaceutical dosage form [11, 11g] may be formed by embossing, oblation, inkjet printing, or tampon printing. The revealing layer [12, 12g] of the Moiré pair can be part of a blister package containing the pharmaceutical dosage form [11, 11g], so that the Moiré effect is observable while looking at the pharmaceutical dosage form [11, 11g] as it remains within the package.Type: ApplicationFiled: April 16, 2010Publication date: October 20, 2011Applicant: I-PROPERTY HOLDING CORP.Inventors: Stefan Klocke, Harald Walter, Alexander Stuck
-
Publication number: 20110256219Abstract: A solid pharmaceutical dosage form [19] has micro- or nanostructures [10a, 10b, 10c, 10d] impressed on the surface thereof or an interface thereof. The dosage form [19] includes a suitable quantity and distribution of ingredients, such as one or more dyes, so as to enhance the optical contrast effect, C, caused by the micro- or nanostructures so that the micro- or nanostructures are observable by the human eye and thereby able to provide anti-counterfeiting characteristics to the dosage form.Type: ApplicationFiled: April 16, 2010Publication date: October 20, 2011Applicant: I-Property Holding Corp.Inventors: Stefan Klocke, Harald Walter, Alexander Stuck
-
Publication number: 20110186629Abstract: The present invention relates to a method for the authentication of dosage forms such as tablets, in particular pharmaceutical tablets, by reading, i.e. detecting, code structure from the tablet, reading additional information from the package or on an information sheet, and then comparing the readings to verify authenticity. The code structure may be randomized on a plurality of tablets disposed in identifiable locations in a shared package such that the detected code structures define a unique digital signature for the package of tablets.Type: ApplicationFiled: January 20, 2011Publication date: August 4, 2011Applicant: I-PROPERTY HOLDING CORPInventors: Alexander Stuck, Stefan Klocke, Thomas Gering
-
Publication number: 20110188051Abstract: The present invention relates to a verification method for tracking and tracing tablets, particularly pharmaceutical tablets. It further relates to a visible secure marking or information that is a part of such tablet (10). The invention further relates to tablets suitable for such verification method, processes for manufacturing such tablets, and methods for reading the information.Type: ApplicationFiled: January 20, 2011Publication date: August 4, 2011Applicant: I-PROPERTY HOLDING CORPInventors: Alexander Stuck, Stefan Klocke
-
Publication number: 20110091068Abstract: A method of tracking and tracing tablets, in particular pharmaceutical tablets, includes reading, i.e. detecting, code structure from the tablet, reading additional information from the package on an information sheet, and then comparing the readings to verify authenticity. The code structure may be two-dimensional or three-dimensional. The detected code may further be compared with information stored in a database.Type: ApplicationFiled: July 22, 2010Publication date: April 21, 2011Applicant: I-PROPERTY HOLDING CORPInventors: Alexander Stuck, Stefan Klocke